3.2. Standard treatment
The patients received different standard treatments for AR in various combinations. Twenty-7 patients (90%) were taking antihistamines, 13 (43.3%) were taking nasal corticosteroids, 5 (16.7%) were taking montelukast, 5 (16.7%) were taking sublingual or subcutaneous immunotherapy, and 1 patient (3.3%) had ophthalmic sodium cromoglycate (Table 